Nephros Inc. Board Changes and Officer Compensation Update
Ticker: NEPH · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1196298
| Field | Detail |
|---|---|
| Company | Nephros Inc (NEPH) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: NEPH
TL;DR
Nephros Inc. board shakeup: director out, new one in, exec pay adjustments.
AI Summary
Nephros Inc. announced on February 26, 2025, a change in its board of directors. Specifically, the company reported the departure of a director and the election of a new director, along with updates to its compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board changes and compensation adjustments can introduce uncertainty regarding future strategic direction and executive incentives.
Key Players & Entities
- Nephros Inc. (company) — Registrant
- February 26, 2025 (date) — Date of earliest event reported
- South Orange, New Jersey (location) — Principal executive offices
FAQ
Who is the departing director from Nephros Inc.'s board?
The filing indicates the departure of a director but does not name the individual in the provided text.
Who is the newly elected director at Nephros Inc.?
The filing states the election of a new director but does not provide their name in the provided text.
What specific changes were made to officer compensation arrangements?
The filing mentions updates to compensatory arrangements for certain officers but does not detail the specific changes in the provided text.
What is the principal executive office address for Nephros Inc.?
The principal executive offices are located at 380 Lackawanna Place, South Orange, New Jersey 07079.
What is the SEC file number for Nephros Inc.?
The SEC file number for Nephros Inc. is 001-32288.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding NEPHROS INC (NEPH).